BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1429522)

  • 1. Purification, analysis, and enzymatic activity of recombinant human synovial fluid phospholipase A2 and N-terminal variants.
    Di Marco S; Märki F; Hofstetter H; Schmitz A; van Oostrum J; Grütter MG
    J Biochem; 1992 Sep; 112(3):350-4. PubMed ID: 1429522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human synovial fluid phospholipase A2 and N-terminal variant: kinetic parameters and response to inhibitors.
    Märki F; Hanulak V
    J Biochem; 1993 Jun; 113(6):734-7. PubMed ID: 8370672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Taiwan banded krait phospholipase A2 in Escherichia coli, a fully active enzyme generated by hydrolyzing with aminopeptidase.
    Chang LS; Wu PF; Chang CC
    Biochem Biophys Res Commun; 1996 Aug; 225(3):990-6. PubMed ID: 8780722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression, purification and biochemical comparison of natural and recombinant human non-pancreatic phospholipase A2.
    Johansen B; Kramer RM; Hession C; McGray P; Pepinsky RB
    Biochem Biophys Res Commun; 1992 Aug; 187(1):544-51. PubMed ID: 1520345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human secretory phospholipase A2: purification and characterization of the enzyme for active site studies.
    Stadel JM; Jones C; Livi GP; Hoyle K; Kurdyla J; Roshak A; McLaughlin MM; Pfarr DA; Comer S; Strickler J
    J Mol Recognit; 1992 Dec; 5(4):145-53. PubMed ID: 1339483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid.
    Seilhamer JJ; Pruzanski W; Vadas P; Plant S; Miller JA; Kloss J; Johnson LK
    J Biol Chem; 1989 Apr; 264(10):5335-8. PubMed ID: 2925608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning, expression, and purification of porcine pancreatic phospholipase A2 and mutants.
    Verheij HM; de Haas GH
    Methods Enzymol; 1991; 197():214-23. PubMed ID: 2051915
    [No Abstract]   [Full Text] [Related]  

  • 8. Phospholipase A2 from human synovial fluid: purification and structural homology to the placental enzyme.
    Lai CY; Wada K
    Biochem Biophys Res Commun; 1988 Dec; 157(2):488-93. PubMed ID: 3202859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of a phospholipase A2 from human osteoarthritic synovial fluid.
    Parks TP; Lukas S; Hoffman AF
    Adv Exp Med Biol; 1990; 275():55-81. PubMed ID: 2146857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asp-49 is not an absolute prerequisite for the enzymic activity of low-M(r) phospholipases A2: purification, characterization and computer modelling of an enzymically active Ser-49 phospholipase A2, ecarpholin S, from the venom of Echis carinatus sochureki (saw-scaled viper).
    Polgár J; Magnenat EM; Peitsch MC; Wells TN; Clemetson KJ
    Biochem J; 1996 Nov; 319 ( Pt 3)(Pt 3):961-8. PubMed ID: 8921006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of the head-group selectivity of porcine pancreatic phospholipase A2 by protein engineering.
    Bhat MK; Pickersgill RW; Perry BN; Brown RA; Jones ST; Mueller-Harvey I; Sumner IG; Goodenough PW
    Biochemistry; 1993 Nov; 32(45):12203-8. PubMed ID: 8105891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-level expression in Escherichia coli and rapid purification of enzymatically active honey bee venom phospholipase A2.
    Dudler T; Chen WQ; Wang S; Schneider T; Annand RR; Dempcy RO; Crameri R; Gmachl M; Suter M; Gelb MH
    Biochim Biophys Acta; 1992 Dec; 1165(2):201-10. PubMed ID: 1450215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipase A2 engineering. Deletion of the C-terminus segment changes substrate specificity and uncouples calcium and substrate binding at the zwitterionic interface.
    Huang B; Yu BZ; Rogers J; Byeon IJ; Sekar K; Chen X; Sundaralingam M; Tsai MD; Jain MK
    Biochemistry; 1996 Sep; 35(37):12164-74. PubMed ID: 8810924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of recombinant human secretory phospholipase A2 (group II) produced in long-term immobilized cell culture.
    Levin W; Daniel RF; Stoner CR; Stoller TJ; Wardwell-Swanson JA; Angelillo YM; Familletti PC; Crowl RM
    Protein Expr Purif; 1992 Feb; 3(1):27-35. PubMed ID: 1422206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of phospholipase A2 (PLA2) from Taiwan Cobra: isoenzymes and their site-directed mutants.
    Pan FM; Chao SC; Wu SH; Chang WC; Chiou SH
    Biochem Biophys Res Commun; 1998 Sep; 250(1):154-60. PubMed ID: 9735349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and properties of a human non-pancreatic phospholipase A2.
    Kramer RM; Hession C; Johansen B; Hayes G; McGray P; Chow EP; Tizard R; Pepinsky RB
    J Biol Chem; 1989 Apr; 264(10):5768-75. PubMed ID: 2925633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial expression and characterization of human pancreatic phospholipase A2.
    Han SK; Lee BI; Cho W
    Biochim Biophys Acta; 1997 Jun; 1346(2):185-92. PubMed ID: 9219901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renaturation of cobra venom phospholipase A2 expressed from a synthetic gene in Escherichia coli.
    Kelley MJ; Crowl RM; Dennis EA
    Biochim Biophys Acta; 1992 Jan; 1118(2):107-15. PubMed ID: 1730025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic activity and immunoreactivity of extracellular phospholipase A2 in inflammatory synovial fluids.
    Pruzanski W; Scott K; Smith G; Rajkovic I; Stefanski E; Vadas P
    Inflammation; 1992 Oct; 16(5):451-7. PubMed ID: 1428121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of surface hydrophobic residues in the interfacial catalysis of bovine pancreatic phospholipase A2.
    Lee BI; Yoon ET; Cho W
    Biochemistry; 1996 Apr; 35(13):4231-40. PubMed ID: 8672459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.